Multiple Non-coding ANRIL Transcripts Are Associated with Risk of Coronary Artery Disease: a Promising Circulating

Juan Fang1, Zhicheng Pan1, Dongfei Wang1

  • 1Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, 79 Qingchun Road, Hangzhou, 310003, Zhejiang, China.

Insights

This study investigated ANRIL isoforms in coronary artery disease (CAD). Circulating circANRIL(exon14-4) showed potential as a biomarker for diagnosing CAD and predicting major adverse cardiovascular events (MACE).

Area of Science:

  • Molecular Biology
  • Cardiovascular Disease Research
  • Biomarker Discovery

Background:

  • ANRIL is a long non-coding RNA with multiple transcriptional isoforms.
  • Dysregulation of ANRIL isoforms is implicated in various diseases, including cardiovascular conditions.
  • The diagnostic and prognostic utility of specific ANRIL isoforms in coronary artery disease (CAD) requires further investigation.

Purpose of the Study:

  • To explore the diagnostic value of six ANRIL transcriptional isoforms in patients with coronary artery disease (CAD).
  • To identify the most promising ANRIL isoform as a circulating biomarker for CAD.
  • To evaluate the prognostic value of the identified biomarker in relation to clinical outcomes and major adverse cardiovascular events (MACE).

Main Methods:

  • Selection and measurement of six target ANRIL isoforms' expression in peripheral blood of CAD patients and controls.
  • Evaluation of diagnostic performance of individual ANRIL isoforms.
  • Validation of the diagnostic and prognostic value of the best-performing isoform in a larger clinical cohort.
  • Correlation analysis between circANRIL(exon14-4) expression levels and MACE incidence.

Main Results:

  • lncANRIL(exon1) and lncANRIL(exon4-6) were significantly increased in CAD patients, while circANRIL(exon14-4) was downregulated.
  • circANRIL(exon14-4) demonstrated the highest diagnostic value among the evaluated isoforms.
  • Lower expression of circANRIL(exon14-4) was significantly associated with an increased incidence of MACE.
  • Combination of circANRIL(exon14-4) with other factors improved CAD patient differentiation.

Conclusions:

  • circANRIL(exon14-4) exhibits significant diagnostic value for coronary artery disease.
  • Downregulation of circANRIL(exon14-4) is linked to increased risk and severity of CAD.
  • circANRIL(exon14-4) represents a promising circulating biomarker for both the diagnosis and prognosis of CAD.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
425
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
771
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
276
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
520
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
680
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
270